Ibrutinib Blocks YAP1 Activation and Reverses BRAF Inhibitor Resistance in Melanoma Cells.

Misek SA, Newbury PA, Chekalin E, Paithankar S, Doseff AI, Chen B, Gallo KA, Neubig RR
Mol Pharmacol. 2022 Jan;101(1):1-12. doi: 10.1124/molpharm.121.000331. Epub 2021 Nov 3. PubMed Article

Plasmids from Article

No plasmids are currently publicly available from Addgene for this article.